Manufacturing and Production

Showing 15 posts of 5813 posts found.

EDQM takes issue with more Chinese APIs

May 5, 2009 Manufacturing and Production Asia, China

The European Directorate on the Quality of Medicines has suspended the certificates of suitability (CEPs) of four active pharmaceutical ingredients …

Patheon takeover stymied by regulators

April 28, 2009 Manufacturing and Production Patheon

A hostile takeover bid for Canadian contract manufacturer Patheon by private equity firm JLL Partners has been blocked by the …

Mixed news for Biogen Idec on Tysabri

April 27, 2009 Manufacturing and Production Biogen

Biogen Idec has won approval for a new high-titre manufacturing process for its multiple sclerosis product Tysabri (natalizumab) which should …

Deal brings single ASEAN pharma market closer

April 22, 2009 Manufacturing and Production Asia

An accord signed by economic ministers of the Association of Southeast Asian Nations, aimed at bringing manufacturing standards into line, …

Sanofi manufacturing plant closed by Italian earthquake

April 17, 2009 Manufacturing and Production Europe, Italy, Sanofi-Aventis

A manufacturing facility operated by Sanofi-Aventis in Abruzzo, Italy, remains closed following the earthquake that claimed more than 280 lives …

Amgen cuts back at US pilot plant

April 16, 2009 Manufacturing and Production Amgen

The worlds largest biotech company, Amgen, is cutting 100 staff at its production facility in Bothell, Washington, as part of …

Shire to close small molecule plant

April 14, 2009 Manufacturing and Production Shire

Shire Pharmaceuticals is shutting down a US production facility and will outsource the production to contract manufacturers DSM.The measure is …

Consortium wins US biodefence contract

April 3, 2009 Manufacturing and Production biologics, vaccines

A consortium of US and UK companies has been awarded an $11 million grant from the US Government to speed …

Bayer Schering Pharma restricts UK distribution

April 2, 2009 Manufacturing and Production Bayer

Bayer Schering Pharma has joined the ranks of firms switching to restrictive distribution arrangements in the UK. The pharma company, …

Patients to get counterfeit warning with each prescription

March 31, 2009 Manufacturing and Production counterfeits

New guidance to patients to raise public awareness of fake medicine and its dangers has been launched by the RPSGB …

Merck hikes investment in Irish biologics plant

March 30, 2009 Manufacturing and Production Europe, Ireland

Merck & Co has increased its investment in a new biologic and vaccines facility in Carlow, Ireland, to 220 million …

Small and flexible: the manufacturing of tomorrow

March 24, 2009 Manufacturing and Production biologics

Biopharmaceutical manufacturing is likely to undergo a dramatic change over the next 20 years, with the today's facilities facing dramatic …

Mannkind picks up Pfizer’s Exubera facility

March 16, 2009 Manufacturing and Production Mannkind, diabetes

The demise of Pfizer's inhaled diabetes treatment Exubera cast a pall over the prospects for inhaled insulin therapy, but has …

Latest content